A new gene therapy called AMT-130 has shown promising results in slowing the progression of Huntington’s disease, according to the latest results from a global clinical trial.
Dr Michael Wangler, Assistant Professor at Molecular and Human Genetics Baylor College of Medicine and Katie Sacra, Director of Family Programs, Global Foundation for Peroxisomal Disorders, mother of TJ, discusses the impact of the COVID-19 pandemic on families with rare disease - especially peroxisomal disorders.
Kym Ward, Dementia Project Coordinator at The Brain Charity, offers insight into how to support those living with dementia during times of uncertainty and isolation.
Climate change is set to rise temperatures globally through greenhouse gas emissions, amidst this change, rates of infectious diseases are to become increasingly difficult to predict.
After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, provides a fresh perspective on predictions concerning Huntington’s disease in a post-pandemic era.
Data reveals that patients with heart disease who come from disadvantaged communities experience more complications after their surgery – including a higher risk of death.
Though the UK’s recommended alcohol limit is under 14 units weekly, researchers still suggest less, as the risk of cardiovascular diseases can still be increased by even moderate amounts.
